PFP BIOSCIENCES
PFP Biosciences is a privately held life sciences venture capital firm focusing on preclinical or early clinical stage assets.
PFP BIOSCIENCES
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-30 | NervGen Pharma | PFP Biosciences investment in Post-IPO Equity - NervGen Pharma | 15.23 M USD |
More informations about "PFP Biosciences"
NervGen Pharma Closes US$15MM Private Placement and …
Jul 14, 2022 In connection with the Private Placement, Adam Rogers, MD, Manager of PFP Biosciences Holdings (“PFP Biosciences”), has been appointed to NervGen’s Board of …See details»
NervGen Completes $23 Million Bought Deal Financing
Mar 28, 2024 Prior to the Offering, PFP Biosciences owned and controlled 10,000,000 Common Shares and 5,000,000 Warrants of NervGen. Subsequent to the Offering, PFP Biosciences …See details»
NERVGEN PHARMA CLOSES US$15MM PRIVATE PLACEMENT …
Jul 14, 2022 2007 he has served on the board of One Family Inc., an organization whose mission is to end homelessness in Massachusetts. He is a member of the Emory University …See details»
NervGen Pharma Provides Update On Closing Of Private Placement
Jul 11, 2022 One of the participants in the Private Placement, PFP Biosciences Holdings (“PFP Biosciences”), has agreed to subscribe for a number of units that will exceed 10% of the …See details»
PFP Biosciences Holdings investment portfolio - PitchBook
Jul 14, 2022 PFP Biosciences Holdings's latest investment was on 14-Jul-2022 in NervGen Pharma, a company within the Biotechnology industry. Data Transparency. Meet our data …See details»
PFP Biosciences - Investments, Portfolio & Company Exits
Jun 30, 2022 PFP Biosciences has invested in NervGen Pharma on Jun 30, 2022. This investment - Post-IPO Equity - NervGen Pharma - was valued at . obfuscated. obfuscated. …See details»
PFP Biosciences - Crunchbase
PFP Biosciences is a privately held life sciences venture capital firm focusing on preclinical or early clinical stage assets. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
PFP Biosciences - Drug pipelines, Patents, Clinical trials - Synapse
Dec 10, 2024 Last update 01 Nov 2024. PFP Biosciences. Private Company |See details»
Pfp Biosciences Holdings LLC - Drug pipelines, Patents, Clinical …
Explore Pfp Biosciences Holdings LLC with its drug pipeline, therapeutic area, technology platform, 3 news. Biomedical products. Data. Feature. Plans. Sign Up for Free. Request …See details»
PFP Biosciences – Investors Database – Unicorn Nest
PFP Biosciences. SAVE. Total investments. 1. Average round size. 15M. Portfolio companies. 1. Exits. 1. Areas of investment Biotechnology Medical Pharmaceutical. Investments analytics …See details»
NervGen Pharma Corp. announced that it has received $15.225 …
On July 13, 2022, NervGen Pharma Corp. closed the transaction. The transaction included participation from new investor, PFP Biosciences Holdings for $15,000,000 and acquired …See details»
NervGen Pharma Closes US$15MM Private Placement and …
Jul 14, 2022 Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a clinical stage biotech …See details»
NervGen Pharma Announces Leadership Transition - BioSpace
Sep 23, 2022 Adam Rogers, MD, is a Principal of Boston-based PFP Biosciences Holdings and a board-certified ophthalmologist specializing in diseases and surgery of the retina and …See details»
PFP Biosciences - VC Firm Profile - Gaebler.com Venture Capital …
Jul 14, 2022 PFP Biosciences has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know. Tech CompanySee details»
NERVGEN PHARMA PROVIDES UPDATE ON CLOSING OF PRIVATE …
Jul 11, 2022 One of the participants in the Private Placement, PFP Biosciences Holdings (“PFP iosciences”), has agreed to subscribe for a number of units that will exceed 10% of the issued …See details»
Hemera Biosciences, Inc. (Hemera Biosciences, Inc.) - 药物管线_专 …
Adam Rogers, MD, is a Principal of Boston-based PFP Biosciences Holdings and a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous. Dr. …See details»
PFP Biosciences - Updates, News, Events, Signals & Triggers
PFP Biosciences is a privately held life sciences venture capital firm focusing on preclinical or early clinical stage assets. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
NervGen Pharma - Funding, Financials, Valuation & Investors
Organization. NervGen Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Stock Symbol TSXV:NGEN. …See details»
NervGen Pharma Provides Update on Closing of Private Placement
Jul 11, 2022 One of the participants in the Private Placement, PFP Biosciences Holdings ("PFP Biosciences"), has agreed to subscribe for a number of units that will exceed 10% of the …See details»
Pacira BioSciences Reaffirms Commitment to Enhancing Value
1 day ago The company has made meaningful progress advancing its 5x30 strategy to transition into an innovative biopharmaceutical organization and become a therapeutic area leader in …See details»